Valsartan: more than a decade of experience
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - Springer
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
[PDF][PDF] More Than a Decade of Experience
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - laboratoriochile.cl
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
[引用][C] Valsartan More Than a Decade of Experience
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - hero.epa.gov
[引用][C] Valsartan: More Than a Decade of Experience
HR BLACK, J BAILEY, D ZAPPE, R SAMUEL - Drugs (Basel), 2009 - pascal-francis.inist.fr
Valsartan: More Than a Decade of Experience CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …
and Francis Bibliographic Databases Simple search Advanced search Search by …
Valsartan
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - search.proquest.com
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
Valsartan: more than a decade of experience.
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - europepmc.org
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
Valsartan: more than a decade of experience
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - go.gale.com
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
Valsartan: More Than a Decade of Experience.
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - search.ebscohost.com
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
Valsartan: more than a decade of experience
HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - pubmed.ncbi.nlm.nih.gov
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …